C4 Therapeutics, Inc. Profile Avatar - Palmy Investing

C4 Therapeutics, Inc.

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7…

Biotechnology
US, Watertown [HQ]

Balance Sheet

Loading...
End of CCCC's Analysis
CIK: 1662579 CUSIP: 12529R107 ISIN: US12529R1077 LEI: - UEI: -
Secondary Listings
CCCC has no secondary listings inside our databases.